Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.77% inched 0.91% higher to $181.09 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.16% rising 2.47% to 4,158.24 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.42% rising 1.76% to 33,212.96. The stock's rise snapped a two-day losing streak. Johnson & Johnson closed $5.60 below its 52-week high ($186.69), which the company achieved on April 25th.
The stock outperformed some of its competitors Friday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/composite RHHVF -1.25% fell 0.41% to $347.00, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +0.24% rose 0.83% to $93.08, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -1.28% fell 0.15% to $53.91. Trading volume (5.8 M) remained 1.7 million below its 50-day average volume of 7.5 M.